Comprehensive analysis of cellular heterogeneity in the tumor microenvironment reveals TUBG1 as an immunosuppressive regulator in hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Heliyon

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.heliyon.2025.e44155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition

  2024cited by this paper
• Upregulation of TUBG1 expression promotes hepatocellular carcinoma development

  2023cited by this paper
• Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis

  2023cited by this paper
• TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways.

  2023cited by this paper
• CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

  2023cited by this paper
• SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma

  2022cited by this paper
• Targeting TGF-β signal transduction for fibrosis and cancer therapy

  2022cited by this paper
• Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer

  2022cited by this paper
• Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?

  2022cited by this paper
• Single‐cell RNA sequencing technologies and applications: A brief overview

  2022cited by this paper
• Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma

  2022cited by this paper
• Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade

  2022cited by this paper
• Tumor‐associated macrophages in liver cancer: From mechanisms to therapy

  2022cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages

  2021cited by this paper
• A commentary on: “A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells” – tumor microenvironment: the Achilles heel of cancer

  2021cited by this paper
• Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials

  2021cited by this paper
• Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells

  2021cited by this paper
• The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia

  2021cited by this paper
• Advances in immunotherapy for hepatocellular carcinoma

  2021cited by this paper
• Cellular heterogeneity and plasticity in liver cancer.

  2021cited by this paper
• Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.

  2021cited by this paper
• Tumor microenvironment as a therapeutic target in cancer.

  2020cited by this paper
• Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma

  2020cited by this paper
• Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data

  2020cited by this paper
• Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases

  2020cited by this paper
• From genome sequencing to the discovery of potential biomarkers in liver disease

  2020cited by this paper
• Microtubule-organizing center-mediated structural atypia in low- and high-grade urothelial carcinoma

  2020cited by this paper
• Inference and analysis of cell-cell communication using CellChat

  2020cited by this paper
• BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway

  2020cited by this paper
• Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins

  2020cited by this paper
• Adjuvant systemic treatment in hepatocellular carcinoma: tempted to do something, rather than nothing.

  2020cited by this paper
• Revolutionizing immunology with single-cell RNA sequencing

  2019cited by this paper
• Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

  2019cited by this paper
• Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.

  2019cited by this paper
• CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.

  2019cited by this paper
• Role of hypoxia in cancer therapy by regulating the tumor microenvironment

  2019cited by this paper
• Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.

  2019cited by this paper
• Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas

  2019cited by this paper
• Hypoxia-Induced Phenotypes that Mediate Tumor Heterogeneity.

  2019cited by this paper
• TUBG1 missense variants underlying cortical malformations disrupt neuronal locomotion and microtubule dynamics but not neurogenesis

  2019cited by this paper
• SMAD4 promotes TGF-&bgr;–independent NK cell homeostasis and maturation and antitumor immunity

  2018cited by this paper
• Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing

  2018cited by this paper
• Lineage tracking reveals dynamic relationships of T cells in colorectal cancer

  2018cited by this paper
• The multiple functions and mechanisms of osteopontin.

  2018cited by this paper
• Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.

  2017cited by this paper
• Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.

  2017cited by this paper
• Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.

  2017cited by this paper
• CDK4/6 inhibition triggers anti-tumor immunity

  2017cited by this paper
• Targeting TGF-β Signaling in Cancer.

  2017cited by this paper
• An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

  2017cited by this paper
• SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling

  2017cited by this paper
• Targeting immunosuppressive adenosine in cancer

  2017cited by this paper
• Heterogeneity of liver cancer and personalized therapy.

  2016cited by this paper
• VEGF targets the tumour cell

  2013cited by this paper
• Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

  2007cited by this paper
• Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

  2007cited by this paper
• Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma.

  2000cited by this paper
• Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

  1981cited by this paper

• No citing papers are available for this paper.